GeneDx Holdings Corp.
WGS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $117 | $103 | $87 | $96 |
| % Growth | 13.7% | 17.9% | -8.9% | – |
| Cost of Goods Sold | $32 | $32 | $29 | $29 |
| Gross Profit | $85 | $71 | $58 | $66 |
| % Margin | 72.4% | 69% | 67.1% | 69.2% |
| R&D Expenses | $20 | $15 | $13 | $12 |
| G&A Expenses | $44 | $27 | $32 | $27 |
| SG&A Expenses | $68 | $46 | $50 | $45 |
| Sales & Mktg Exp. | $24 | $19 | $18 | $18 |
| Other Operating Expenses | $0 | $1 | $0 | $1 |
| Operating Expenses | $88 | $62 | $63 | $57 |
| Operating Income | -$3 | $9 | -$5 | $9 |
| % Margin | -2.8% | 8.7% | -5.2% | 9.2% |
| Other Income/Exp. Net | -$4 | $2 | -$2 | -$3 |
| Pre-Tax Income | -$7 | $11 | -$6 | $5 |
| Tax Expense | $0 | -$0 | $0 | -$0 |
| Net Income | -$8 | $11 | -$7 | $5 |
| % Margin | -6.5% | 10.5% | -7.5% | 5.7% |
| EPS | -0.27 | 0.38 | -0.23 | 0.2 |
| % Growth | -171.1% | 265.2% | -215% | – |
| EPS Diluted | -0.27 | 0.36 | -0.23 | 0.2 |
| Weighted Avg Shares Out | 29 | 29 | 28 | 27 |
| Weighted Avg Shares Out Dil | 29 | 30 | 28 | 27 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $6 | $6 | $6 | $6 |
| EBITDA | -$0 | $18 | $0 | $14 |
| % Margin | -0.3% | 17.1% | 0.3% | 15% |